nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfacetamide—Hepatic necrosis—Flutamide—prostate cancer	0.0513	0.0571	CcSEcCtD
Sulfacetamide—Blood disorder—Bicalutamide—prostate cancer	0.0259	0.0288	CcSEcCtD
Sulfacetamide—Dermatitis bullous—Flutamide—prostate cancer	0.0227	0.0252	CcSEcCtD
Sulfacetamide—Blister—Conjugated Estrogens—prostate cancer	0.0207	0.023	CcSEcCtD
Sulfacetamide—Lupus erythematosus—Docetaxel—prostate cancer	0.0206	0.0229	CcSEcCtD
Sulfacetamide—Toxic epidermal necrolysis—Flutamide—prostate cancer	0.0195	0.0217	CcSEcCtD
Sulfacetamide—Secondary infection—Epirubicin—prostate cancer	0.0176	0.0196	CcSEcCtD
Sulfacetamide—Secondary infection—Doxorubicin—prostate cancer	0.0163	0.0182	CcSEcCtD
Sulfacetamide—Erythema multiforme—Estrone—prostate cancer	0.0153	0.017	CcSEcCtD
Sulfacetamide—Systemic lupus erythematosus—Docetaxel—prostate cancer	0.0139	0.0154	CcSEcCtD
Sulfacetamide—Erythema multiforme—Estradiol valerate/Dienogest—prostate cancer	0.0134	0.0149	CcSEcCtD
Sulfacetamide—Erythema—Flutamide—prostate cancer	0.013	0.0145	CcSEcCtD
Sulfacetamide—Oedema—Estramustine—prostate cancer	0.0121	0.0134	CcSEcCtD
Sulfacetamide—Oedema—Abiraterone—prostate cancer	0.0117	0.013	CcSEcCtD
Sulfacetamide—Erythema—Degarelix—prostate cancer	0.0117	0.013	CcSEcCtD
Sulfacetamide—Infection—Abiraterone—prostate cancer	0.0116	0.0129	CcSEcCtD
Sulfacetamide—Oedema—Estrone—prostate cancer	0.0115	0.0128	CcSEcCtD
Sulfacetamide—Dermatitis bullous—Conjugated Estrogens—prostate cancer	0.0113	0.0126	CcSEcCtD
Sulfacetamide—Erythema—Cabazitaxel—prostate cancer	0.011	0.0123	CcSEcCtD
Sulfacetamide—Sulfamethoxazole—NAT1—prostate cancer	0.011	0.109	CrCbGaD
Sulfacetamide—Oedema—Nilutamide—prostate cancer	0.0107	0.0119	CcSEcCtD
Sulfacetamide—Oedema—Flutamide—prostate cancer	0.0106	0.0118	CcSEcCtD
Sulfacetamide—Blister—Capecitabine—prostate cancer	0.0103	0.0115	CcSEcCtD
Sulfacetamide—Oedema—Estradiol valerate/Dienogest—prostate cancer	0.01	0.0112	CcSEcCtD
Sulfacetamide—Acetaminophen—SULT1E1—prostate cancer	0.00998	0.0988	CrCbGaD
Sulfacetamide—Pain—Estrone—prostate cancer	0.00984	0.011	CcSEcCtD
Sulfacetamide—Pain—Nilutamide—prostate cancer	0.00914	0.0102	CcSEcCtD
Sulfacetamide—Oedema—Cabazitaxel—prostate cancer	0.009	0.01	CcSEcCtD
Sulfacetamide—Infection—Cabazitaxel—prostate cancer	0.00894	0.00994	CcSEcCtD
Sulfacetamide—Erythema multiforme—Ethinyl Estradiol—prostate cancer	0.00868	0.00966	CcSEcCtD
Sulfacetamide—Pain—Estradiol valerate/Dienogest—prostate cancer	0.00859	0.00956	CcSEcCtD
Sulfacetamide—Pruritus—Estramustine—prostate cancer	0.00853	0.00948	CcSEcCtD
Sulfacetamide—Acetaminophen—SULT1A1—prostate cancer	0.00848	0.084	CrCbGaD
Sulfacetamide—Acetaminophen—SULT2A1—prostate cancer	0.00848	0.084	CrCbGaD
Sulfacetamide—Pain—Degarelix—prostate cancer	0.00817	0.00909	CcSEcCtD
Sulfacetamide—Pruritus—Estrone—prostate cancer	0.00814	0.00906	CcSEcCtD
Sulfacetamide—Acetaminophen—UGT2B15—prostate cancer	0.00798	0.079	CrCbGaD
Sulfacetamide—Oedema—Bicalutamide—prostate cancer	0.00772	0.00859	CcSEcCtD
Sulfacetamide—Pain—Cabazitaxel—prostate cancer	0.00769	0.00856	CcSEcCtD
Sulfacetamide—Infection—Bicalutamide—prostate cancer	0.00767	0.00853	CcSEcCtD
Sulfacetamide—Pruritus—Nilutamide—prostate cancer	0.00757	0.00842	CcSEcCtD
Sulfacetamide—Pruritus—Flutamide—prostate cancer	0.00753	0.00838	CcSEcCtD
Sulfacetamide—Hypersensitivity—Estradiol valerate/Dienogest—prostate cancer	0.0074	0.00823	CcSEcCtD
Sulfacetamide—Blister—Epirubicin—prostate cancer	0.00719	0.008	CcSEcCtD
Sulfacetamide—Pruritus—Estradiol valerate/Dienogest—prostate cancer	0.00711	0.00791	CcSEcCtD
Sulfacetamide—Erythema multiforme—Conjugated Estrogens—prostate cancer	0.00708	0.00787	CcSEcCtD
Sulfacetamide—Hypersensitivity—Degarelix—prostate cancer	0.00704	0.00783	CcSEcCtD
Sulfacetamide—Pruritus—Degarelix—prostate cancer	0.00676	0.00752	CcSEcCtD
Sulfacetamide—Blister—Doxorubicin—prostate cancer	0.00665	0.0074	CcSEcCtD
Sulfacetamide—Hypersensitivity—Cabazitaxel—prostate cancer	0.00663	0.00737	CcSEcCtD
Sulfacetamide—Pain—Bicalutamide—prostate cancer	0.0066	0.00734	CcSEcCtD
Sulfacetamide—Erythema—Goserelin—prostate cancer	0.00658	0.00732	CcSEcCtD
Sulfacetamide—Oedema—Ethinyl Estradiol—prostate cancer	0.00652	0.00726	CcSEcCtD
Sulfacetamide—Erythema—Conjugated Estrogens—prostate cancer	0.00652	0.00725	CcSEcCtD
Sulfacetamide—Infection—Ethinyl Estradiol—prostate cancer	0.00648	0.00721	CcSEcCtD
Sulfacetamide—Stinging—Epirubicin—prostate cancer	0.0064	0.00712	CcSEcCtD
Sulfacetamide—Blood disorder—Epirubicin—prostate cancer	0.00621	0.0069	CcSEcCtD
Sulfacetamide—Toxic epidermal necrolysis—Etoposide—prostate cancer	0.00604	0.00672	CcSEcCtD
Sulfacetamide—Stinging—Doxorubicin—prostate cancer	0.00592	0.00659	CcSEcCtD
Sulfacetamide—Dermatitis bullous—Docetaxel—prostate cancer	0.00584	0.00649	CcSEcCtD
Sulfacetamide—Agranulocytosis—Mitoxantrone—prostate cancer	0.0058	0.00646	CcSEcCtD
Sulfacetamide—Blood disorder—Doxorubicin—prostate cancer	0.00574	0.00639	CcSEcCtD
Sulfacetamide—Hypersensitivity—Bicalutamide—prostate cancer	0.00569	0.00633	CcSEcCtD
Sulfacetamide—Erythema multiforme—Estradiol—prostate cancer	0.00567	0.0063	CcSEcCtD
Sulfacetamide—Dermatitis bullous—Capecitabine—prostate cancer	0.00565	0.00629	CcSEcCtD
Sulfacetamide—Pruritus—Bicalutamide—prostate cancer	0.00546	0.00607	CcSEcCtD
Sulfacetamide—Oedema—Goserelin—prostate cancer	0.00537	0.00597	CcSEcCtD
Sulfacetamide—Infection—Goserelin—prostate cancer	0.00533	0.00593	CcSEcCtD
Sulfacetamide—Oedema—Conjugated Estrogens—prostate cancer	0.00532	0.00592	CcSEcCtD
Sulfacetamide—Infection—Conjugated Estrogens—prostate cancer	0.00528	0.00588	CcSEcCtD
Sulfacetamide—Erythema—Estradiol—prostate cancer	0.00522	0.0058	CcSEcCtD
Sulfacetamide—Stevens-Johnson syndrome—Etoposide—prostate cancer	0.00513	0.0057	CcSEcCtD
Sulfacetamide—Toxic epidermal necrolysis—Docetaxel—prostate cancer	0.00502	0.00559	CcSEcCtD
Sulfacetamide—Aplastic anaemia—Epirubicin—prostate cancer	0.00487	0.00541	CcSEcCtD
Sulfacetamide—Toxic epidermal necrolysis—Capecitabine—prostate cancer	0.00486	0.00541	CcSEcCtD
Sulfacetamide—Erythema—Mitoxantrone—prostate cancer	0.00486	0.00541	CcSEcCtD
Sulfacetamide—Agranulocytosis—Etoposide—prostate cancer	0.00483	0.00537	CcSEcCtD
Sulfacetamide—Hypersensitivity—Ethinyl Estradiol—prostate cancer	0.00481	0.00535	CcSEcCtD
Sulfacetamide—Pruritus—Ethinyl Estradiol—prostate cancer	0.00462	0.00513	CcSEcCtD
Sulfacetamide—Pain—Goserelin—prostate cancer	0.00459	0.00511	CcSEcCtD
Sulfacetamide—Pain—Conjugated Estrogens—prostate cancer	0.00455	0.00506	CcSEcCtD
Sulfacetamide—Aplastic anaemia—Doxorubicin—prostate cancer	0.0045	0.00501	CcSEcCtD
Sulfacetamide—Erythema multiforme—Etoposide—prostate cancer	0.00439	0.00488	CcSEcCtD
Sulfacetamide—Stevens-Johnson syndrome—Docetaxel—prostate cancer	0.00426	0.00474	CcSEcCtD
Sulfacetamide—Oedema—Estradiol—prostate cancer	0.00426	0.00474	CcSEcCtD
Sulfacetamide—Infection—Estradiol—prostate cancer	0.00423	0.0047	CcSEcCtD
Sulfacetamide—Acetaminophen—NAT2—prostate cancer	0.00414	0.041	CrCbGaD
Sulfacetamide—Stevens-Johnson syndrome—Capecitabine—prostate cancer	0.00413	0.00459	CcSEcCtD
Sulfacetamide—Agranulocytosis—Docetaxel—prostate cancer	0.00401	0.00446	CcSEcCtD
Sulfacetamide—Oedema—Mitoxantrone—prostate cancer	0.00397	0.00441	CcSEcCtD
Sulfacetamide—Hypersensitivity—Goserelin—prostate cancer	0.00396	0.0044	CcSEcCtD
Sulfacetamide—Infection—Mitoxantrone—prostate cancer	0.00394	0.00438	CcSEcCtD
Sulfacetamide—Dermatitis bullous—Epirubicin—prostate cancer	0.00394	0.00438	CcSEcCtD
Sulfacetamide—Hypersensitivity—Conjugated Estrogens—prostate cancer	0.00392	0.00436	CcSEcCtD
Sulfacetamide—Agranulocytosis—Capecitabine—prostate cancer	0.00388	0.00432	CcSEcCtD
Sulfacetamide—Pruritus—Goserelin—prostate cancer	0.0038	0.00423	CcSEcCtD
Sulfacetamide—Pruritus—Conjugated Estrogens—prostate cancer	0.00376	0.00419	CcSEcCtD
Sulfacetamide—Erythema multiforme—Docetaxel—prostate cancer	0.00365	0.00406	CcSEcCtD
Sulfacetamide—Dermatitis bullous—Doxorubicin—prostate cancer	0.00364	0.00405	CcSEcCtD
Sulfacetamide—Pain—Estradiol—prostate cancer	0.00364	0.00405	CcSEcCtD
Sulfacetamide—Erythema multiforme—Capecitabine—prostate cancer	0.00353	0.00393	CcSEcCtD
Sulfacetamide—Sulfamethoxazole—NAT2—prostate cancer	0.00346	0.0343	CrCbGaD
Sulfacetamide—Pain—Mitoxantrone—prostate cancer	0.00339	0.00377	CcSEcCtD
Sulfacetamide—Toxic epidermal necrolysis—Epirubicin—prostate cancer	0.00339	0.00377	CcSEcCtD
Sulfacetamide—Erythema—Docetaxel—prostate cancer	0.00336	0.00374	CcSEcCtD
Sulfacetamide—Infection—Etoposide—prostate cancer	0.00328	0.00365	CcSEcCtD
Sulfacetamide—Erythema—Capecitabine—prostate cancer	0.00325	0.00362	CcSEcCtD
Sulfacetamide—Gliclazide—VEGFA—prostate cancer	0.00316	0.0313	CrCbGaD
Sulfacetamide—Sulfathiazole—CYP19A1—prostate cancer	0.00314	0.0311	CrCbGaD
Sulfacetamide—Hypersensitivity—Estradiol—prostate cancer	0.00314	0.00349	CcSEcCtD
Sulfacetamide—Toxic epidermal necrolysis—Doxorubicin—prostate cancer	0.00314	0.00349	CcSEcCtD
Sulfacetamide—Pruritus—Estradiol—prostate cancer	0.00301	0.00335	CcSEcCtD
Sulfacetamide—Procainamide—DNMT1—prostate cancer	0.00294	0.0291	CrCbGaD
Sulfacetamide—Hypersensitivity—Mitoxantrone—prostate cancer	0.00292	0.00325	CcSEcCtD
Sulfacetamide—Erythema—Prednisone—prostate cancer	0.0029	0.00322	CcSEcCtD
Sulfacetamide—Stevens-Johnson syndrome—Epirubicin—prostate cancer	0.00287	0.0032	CcSEcCtD
Sulfacetamide—Pain—Etoposide—prostate cancer	0.00282	0.00314	CcSEcCtD
Sulfacetamide—Oedema—Docetaxel—prostate cancer	0.00274	0.00305	CcSEcCtD
Sulfacetamide—Infection—Docetaxel—prostate cancer	0.00272	0.00303	CcSEcCtD
Sulfacetamide—Dapsone—NAT2—prostate cancer	0.00271	0.0268	CrCbGaD
Sulfacetamide—Agranulocytosis—Epirubicin—prostate cancer	0.00271	0.00301	CcSEcCtD
Sulfacetamide—Stevens-Johnson syndrome—Doxorubicin—prostate cancer	0.00266	0.00296	CcSEcCtD
Sulfacetamide—Oedema—Capecitabine—prostate cancer	0.00265	0.00295	CcSEcCtD
Sulfacetamide—Infection—Capecitabine—prostate cancer	0.00264	0.00293	CcSEcCtD
Sulfacetamide—Tolbutamide—CYP2C18—prostate cancer	0.00259	0.0256	CrCbGaD
Sulfacetamide—Agranulocytosis—Doxorubicin—prostate cancer	0.0025	0.00279	CcSEcCtD
Sulfacetamide—Erythema multiforme—Epirubicin—prostate cancer	0.00246	0.00274	CcSEcCtD
Sulfacetamide—Hypersensitivity—Etoposide—prostate cancer	0.00243	0.0027	CcSEcCtD
Sulfacetamide—Oedema—Prednisone—prostate cancer	0.00236	0.00263	CcSEcCtD
Sulfacetamide—Infection—Prednisone—prostate cancer	0.00235	0.00261	CcSEcCtD
Sulfacetamide—Pain—Docetaxel—prostate cancer	0.00234	0.00261	CcSEcCtD
Sulfacetamide—Pruritus—Etoposide—prostate cancer	0.00233	0.0026	CcSEcCtD
Sulfacetamide—Erythema multiforme—Doxorubicin—prostate cancer	0.00228	0.00253	CcSEcCtD
Sulfacetamide—Pain—Capecitabine—prostate cancer	0.00227	0.00253	CcSEcCtD
Sulfacetamide—Erythema—Epirubicin—prostate cancer	0.00227	0.00252	CcSEcCtD
Sulfacetamide—Erythema—Doxorubicin—prostate cancer	0.0021	0.00233	CcSEcCtD
Sulfacetamide—Hypersensitivity—Docetaxel—prostate cancer	0.00202	0.00225	CcSEcCtD
Sulfacetamide—Hypersensitivity—Capecitabine—prostate cancer	0.00196	0.00218	CcSEcCtD
Sulfacetamide—Pruritus—Docetaxel—prostate cancer	0.00194	0.00216	CcSEcCtD
Sulfacetamide—Procainamide—SLC22A3—prostate cancer	0.00192	0.019	CrCbGaD
Sulfacetamide—Pruritus—Capecitabine—prostate cancer	0.00188	0.00209	CcSEcCtD
Sulfacetamide—Oedema—Epirubicin—prostate cancer	0.00185	0.00206	CcSEcCtD
Sulfacetamide—Infection—Epirubicin—prostate cancer	0.00184	0.00204	CcSEcCtD
Sulfacetamide—Probenecid—SLC22A1—prostate cancer	0.00179	0.0177	CrCbGaD
Sulfacetamide—Aminohippurate—SLC22A1—prostate cancer	0.00177	0.0175	CrCbGaD
Sulfacetamide—Hypersensitivity—Prednisone—prostate cancer	0.00174	0.00194	CcSEcCtD
Sulfacetamide—Procainamide—ACHE—prostate cancer	0.00174	0.0172	CrCbGaD
Sulfacetamide—Dapsone—CYP2C18—prostate cancer	0.00172	0.017	CrCbGaD
Sulfacetamide—Oedema—Doxorubicin—prostate cancer	0.00171	0.0019	CcSEcCtD
Sulfacetamide—Infection—Doxorubicin—prostate cancer	0.0017	0.00189	CcSEcCtD
Sulfacetamide—Acetaminophen—CYP2A6—prostate cancer	0.00168	0.0166	CrCbGaD
Sulfacetamide—Pruritus—Prednisone—prostate cancer	0.00167	0.00186	CcSEcCtD
Sulfacetamide—Sulfaphenazole—CYP2A6—prostate cancer	0.00166	0.0164	CrCbGaD
Sulfacetamide—Pain—Epirubicin—prostate cancer	0.00158	0.00176	CcSEcCtD
Sulfacetamide—Gliclazide—CYP2C19—prostate cancer	0.00153	0.0152	CrCbGaD
Sulfacetamide—Pain—Doxorubicin—prostate cancer	0.00146	0.00163	CcSEcCtD
Sulfacetamide—Procainamide—SLC22A1—prostate cancer	0.00138	0.0136	CrCbGaD
Sulfacetamide—Hypersensitivity—Epirubicin—prostate cancer	0.00136	0.00152	CcSEcCtD
Sulfacetamide—Pruritus—Epirubicin—prostate cancer	0.00131	0.00146	CcSEcCtD
Sulfacetamide—Sulfadiazine—CYP2E1—prostate cancer	0.00129	0.0127	CrCbGaD
Sulfacetamide—Dapsone—MPO—prostate cancer	0.00128	0.0127	CrCbGaD
Sulfacetamide—Hypersensitivity—Doxorubicin—prostate cancer	0.00126	0.0014	CcSEcCtD
Sulfacetamide—Pruritus—Doxorubicin—prostate cancer	0.00121	0.00135	CcSEcCtD
Sulfacetamide—Acetaminophen—CYP2E1—prostate cancer	0.00119	0.0118	CrCbGaD
Sulfacetamide—Chlorpropamide—CYP2C19—prostate cancer	0.00119	0.0118	CrCbGaD
Sulfacetamide—Acetaminophen—CYP1A1—prostate cancer	0.00118	0.0116	CrCbGaD
Sulfacetamide—Tolbutamide—CYP2C19—prostate cancer	0.00116	0.0115	CrCbGaD
Sulfacetamide—Dapsone—CYP3A5—prostate cancer	0.00113	0.0112	CrCbGaD
Sulfacetamide—Probenecid—CYP2C19—prostate cancer	0.000983	0.00974	CrCbGaD
Sulfacetamide—Sulfanilamide—CYP2E1—prostate cancer	0.000873	0.00864	CrCbGaD
Sulfacetamide—Sulfanilamide—CYP2C19—prostate cancer	0.000865	0.00856	CrCbGaD
Sulfacetamide—Sulfadiazine—CYP3A4—prostate cancer	0.00081	0.00802	CrCbGaD
Sulfacetamide—Dapsone—CYP2E1—prostate cancer	0.000779	0.00771	CrCbGaD
Sulfacetamide—Dapsone—CYP2C19—prostate cancer	0.000772	0.00764	CrCbGaD
Sulfacetamide—Acetaminophen—CYP3A4—prostate cancer	0.00075	0.00743	CrCbGaD
Sulfacetamide—Acetaminophen—PTGS2—prostate cancer	0.000735	0.00727	CrCbGaD
Sulfacetamide—Sulfamethoxazole—CYP3A4—prostate cancer	0.000627	0.00621	CrCbGaD
Sulfacetamide—Probenecid—CYP3A4—prostate cancer	0.000625	0.00619	CrCbGaD
Sulfacetamide—Sulfanilamide—CYP3A4—prostate cancer	0.00055	0.00544	CrCbGaD
Sulfacetamide—Dapsone—CYP3A4—prostate cancer	0.000491	0.00486	CrCbGaD
Sulfacetamide—Dapsone—PTGS2—prostate cancer	0.00048	0.00476	CrCbGaD
